Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,135.95
(
-0.04%
)
US TECH 100
26,522.40
(
0.23%
)
Dow Jones
48,861.81
(
-0.57%
)
Brent Oil
109.09
(
-2.93%
)
Bitcoin
76,090.44
(
0.41%
)
News Focus
News Focus
Post# of 447656
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

HDGabor

Send PM Follow Ignore
Followers 142
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

HDGabor

Re: funnygi2 post# 232768

Wednesday, 12/11/2019 6:12:03 PM

Wednesday, December 11, 2019 6:12:03 PM

Post# of 447656
f-

Do you think they will GIA in Europe*, South America and Rest of world (incl. Australia, NZ, India)?
Do you know that V won't be sell in Japan (one of the biggest - if isn't the biggest - market after the US)?
Are you aware of any prescription drug that generated more revenue ex-US than in the US?

* If you mean that $16 bn in Europe as licensing / revenue share revenue: no way … the % won't be higher than 30% (more likely max. 20-30%) -> 30% = 16 bn = more than 50 bn ...

Best,
G

"There are some things money can't buy. … For these, there is AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News